FGF23 and hypophosphatemia: Although PHEX mutations cause chronic elevation of bone-derived fibroblast growth factor 23 (FGF23) leading to hypophosphatemia and hypomineralization of hard tissues, it is also believed that loss of PHEX contributes locally to the accumulation of organic matrix components leading to defective mineralization (Martin et al., 2008).